Review



dip100 quantikine immunoassay  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    R&D Systems dip100 quantikine immunoassay
    Dip100 Quantikine Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 176 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dip100 quantikine immunoassay/product/R&D Systems
    Average 96 stars, based on 176 article reviews
    dip100 quantikine immunoassay - by Bioz Stars, 2026-05
    96/100 stars

    Images



    Similar Products

    dip100 quantikine immunoassay  (R&D Systems)
    96
    R&D Systems dip100 quantikine immunoassay
    Dip100 Quantikine Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dip100 quantikine immunoassay/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    dip100 quantikine immunoassay - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    human cxcl10 ip 10 immunoassay  (ALPCO)
    95
    ALPCO human cxcl10 ip 10 immunoassay
    Human Cxcl10 Ip 10 Immunoassay, supplied by ALPCO, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cxcl10 ip 10 immunoassay/product/ALPCO
    Average 95 stars, based on 1 article reviews
    human cxcl10 ip 10 immunoassay - by Bioz Stars, 2026-05
    95/100 stars
    		  Buy from Supplier
    human cxcl10 ip 10 immunoassay  (R&D Systems)
    96
    R&D Systems human cxcl10 ip 10 immunoassay
    Human Cxcl10 Ip 10 Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cxcl10 ip 10 immunoassay/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    human cxcl10 ip 10 immunoassay - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    human cxcl10 immunoassay elisa kit  (R&D Systems)
    96
    R&D Systems human cxcl10 immunoassay elisa kit
    Figure 2. Performance of N3-MASH for diag- nosis of MASLD in the discovery and valida- tion cohort (A and B) ROC curve for N3-MASH and individual protein markers <t>(CXCL10</t> and CK-18) in discrimi- nating MASLD from healthy controls in the discovery cohort from Hong Kong, China, by logistic regression (A) and SVM (B). (C and D) ROC curve for N3-MASH and individual protein markers (CXCL10 and CK-18) in discrimi- nating MASH from patients with MASL in the vali- dation cohort from San Diego, USA, by logistic regression (C) and SVM (D). See also Figures S1, S2, and S4 and Tables S2 and S3.
    Human Cxcl10 Immunoassay Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cxcl10 immunoassay elisa kit/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    human cxcl10 immunoassay elisa kit - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    p10011 human cxcl10 ip 10 immunoassay elisa kit r d  (R&D Systems)
    96
    R&D Systems p10011 human cxcl10 ip 10 immunoassay elisa kit r d
    Figure 2. Performance of N3-MASH for diag- nosis of MASLD in the discovery and valida- tion cohort (A and B) ROC curve for N3-MASH and individual protein markers <t>(CXCL10</t> and CK-18) in discrimi- nating MASLD from healthy controls in the discovery cohort from Hong Kong, China, by logistic regression (A) and SVM (B). (C and D) ROC curve for N3-MASH and individual protein markers (CXCL10 and CK-18) in discrimi- nating MASH from patients with MASL in the vali- dation cohort from San Diego, USA, by logistic regression (C) and SVM (D). See also Figures S1, S2, and S4 and Tables S2 and S3.
    P10011 Human Cxcl10 Ip 10 Immunoassay Elisa Kit R D, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p10011 human cxcl10 ip 10 immunoassay elisa kit r d/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    p10011 human cxcl10 ip 10 immunoassay elisa kit r d - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    dip100 human fgf21 immunoassay elisa kit r d  (R&D Systems)
    96
    R&D Systems dip100 human fgf21 immunoassay elisa kit r d
    Figure 2. Performance of N3-MASH for diag- nosis of MASLD in the discovery and valida- tion cohort (A and B) ROC curve for N3-MASH and individual protein markers <t>(CXCL10</t> and CK-18) in discrimi- nating MASLD from healthy controls in the discovery cohort from Hong Kong, China, by logistic regression (A) and SVM (B). (C and D) ROC curve for N3-MASH and individual protein markers (CXCL10 and CK-18) in discrimi- nating MASH from patients with MASL in the vali- dation cohort from San Diego, USA, by logistic regression (C) and SVM (D). See also Figures S1, S2, and S4 and Tables S2 and S3.
    Dip100 Human Fgf21 Immunoassay Elisa Kit R D, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dip100 human fgf21 immunoassay elisa kit r d/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    dip100 human fgf21 immunoassay elisa kit r d - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    quantikine elisa human ip 10 immunoassay  (R&D Systems)
    96
    R&D Systems quantikine elisa human ip 10 immunoassay
    Figure 2. Performance of N3-MASH for diag- nosis of MASLD in the discovery and valida- tion cohort (A and B) ROC curve for N3-MASH and individual protein markers <t>(CXCL10</t> and CK-18) in discrimi- nating MASLD from healthy controls in the discovery cohort from Hong Kong, China, by logistic regression (A) and SVM (B). (C and D) ROC curve for N3-MASH and individual protein markers (CXCL10 and CK-18) in discrimi- nating MASH from patients with MASL in the vali- dation cohort from San Diego, USA, by logistic regression (C) and SVM (D). See also Figures S1, S2, and S4 and Tables S2 and S3.
    Quantikine Elisa Human Ip 10 Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/quantikine elisa human ip 10 immunoassay/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    quantikine elisa human ip 10 immunoassay - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 2. Performance of N3-MASH for diag- nosis of MASLD in the discovery and valida- tion cohort (A and B) ROC curve for N3-MASH and individual protein markers (CXCL10 and CK-18) in discrimi- nating MASLD from healthy controls in the discovery cohort from Hong Kong, China, by logistic regression (A) and SVM (B). (C and D) ROC curve for N3-MASH and individual protein markers (CXCL10 and CK-18) in discrimi- nating MASH from patients with MASL in the vali- dation cohort from San Diego, USA, by logistic regression (C) and SVM (D). See also Figures S1, S2, and S4 and Tables S2 and S3.

    Journal: Cell metabolism

    Article Title: A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis.

    doi: 10.1016/j.cmet.2024.10.008

    Figure Lengend Snippet: Figure 2. Performance of N3-MASH for diag- nosis of MASLD in the discovery and valida- tion cohort (A and B) ROC curve for N3-MASH and individual protein markers (CXCL10 and CK-18) in discrimi- nating MASLD from healthy controls in the discovery cohort from Hong Kong, China, by logistic regression (A) and SVM (B). (C and D) ROC curve for N3-MASH and individual protein markers (CXCL10 and CK-18) in discrimi- nating MASH from patients with MASL in the vali- dation cohort from San Diego, USA, by logistic regression (C) and SVM (D). See also Figures S1, S2, and S4 and Tables S2 and S3.

    Article Snippet: Serum levels of CK-18, FGF21, CXCL10, P62, SQLE, and CA3 were measured by PEVIVA M30-Apoptosense enzyme-linked immunosorbent assay (ELISA) kit (P10011, DiaPharma Group, West Chester, OH), human CXCL10 immunoassay ELISA kit (DIP100, R&D company, Minneapolis, MN), human FGF21 ELISA kit (DF2100, R&D company), human p62/SQSTM1 ELISA Kit (#SED198Hu, Cloud-Clone Corp, Wuhan, China), human SQLE ELISA kit (#SEH135Hu, Cloud-Clone Corp), and human CA3 ELISA kit (#SED070Hu, CloudClone Corp), respectively.

    Techniques:

    Figure 3. Performance of N3-MASH for diag- nosis of MASH in the discovery cohort (A and B) ROC curve for N3-MASH and individual protein markers (CXCL10 and CK-18) in discrimi- nating MASH from patients with MASL in the dis- covery cohort by logistic regression (A) and SVM (B). (C and D) Changes in sensitivity and specificity at varying N3-MASH cutoffs for the diagnosis of MASH in the discovery cohort by logistic regression (C) and SVM (D). See also Figures S1 and S2 and Tables S2, S4, and S5–S7.

    Journal: Cell metabolism

    Article Title: A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis.

    doi: 10.1016/j.cmet.2024.10.008

    Figure Lengend Snippet: Figure 3. Performance of N3-MASH for diag- nosis of MASH in the discovery cohort (A and B) ROC curve for N3-MASH and individual protein markers (CXCL10 and CK-18) in discrimi- nating MASH from patients with MASL in the dis- covery cohort by logistic regression (A) and SVM (B). (C and D) Changes in sensitivity and specificity at varying N3-MASH cutoffs for the diagnosis of MASH in the discovery cohort by logistic regression (C) and SVM (D). See also Figures S1 and S2 and Tables S2, S4, and S5–S7.

    Article Snippet: Serum levels of CK-18, FGF21, CXCL10, P62, SQLE, and CA3 were measured by PEVIVA M30-Apoptosense enzyme-linked immunosorbent assay (ELISA) kit (P10011, DiaPharma Group, West Chester, OH), human CXCL10 immunoassay ELISA kit (DIP100, R&D company, Minneapolis, MN), human FGF21 ELISA kit (DF2100, R&D company), human p62/SQSTM1 ELISA Kit (#SED198Hu, Cloud-Clone Corp, Wuhan, China), human SQLE ELISA kit (#SEH135Hu, Cloud-Clone Corp), and human CA3 ELISA kit (#SED070Hu, CloudClone Corp), respectively.

    Techniques: Biomarker Discovery